Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11891439 Antibodies and assays for CCL14

Patent 11891439 was granted and assigned to Astute Medical on February, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Astute Medical
Astute Medical
0
Date Filed
December 28, 2018
0
Date of Patent
February 6, 2024
0
Patent Applicant
Astute Medical
Astute Medical
0
Patent Application Number
16958072
0
Patent Citations
‌
US Patent 7214775 Method of modulating the activity of functional immune molecules
0
‌
US Patent 6946292 Cells producing antibody compositions with increased antibody dependent cytotoxic activity
0
‌
US Patent 7125493 Highly asymmetric, hydrophilic, microfiltration membranes having large pore diameters
0
‌
US Patent 7657380 Methods of generating variant antibodies with increased host string content
0
Patent Inventor Names
Ravi A Vijayendran
0
Hua Wang
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11891439
0
Patent Primary Examiner
‌
Nora M Rooney
0

Find more entities like US Patent 11891439 Antibodies and assays for CCL14

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo